| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | ACURA PHARMACEUTICALS, INC | ACUR | Exercise | Restricted Stock Units (2021 Plan) | 66.7k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units (2021 Plan) | 50k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2022 | ACURA PHARMACEUTICALS, INC | ACUR | Exercise | Restricted Stock Units (2021 Plan) | 66.7k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units (2021 Plan) | 66.7k | $0.00 | $0 | | 01/03/2022 |
| 05/25/2021 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units (2021 Plan) | 66.7k | $0.00 | $0 | | 05/25/2021 |
| 01/02/2020 | ACURA PHARMACEUTICALS, INC | ACUR | Exercise | Restricted Stock Units (2017 Plan) | 83.3k | $0.00 | $0 | | 01/02/2020 |
| 01/02/2020 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units (2017 Plan) | 54.8k | $0.00 | $0 | | 01/02/2020 |
| 01/02/2019 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units (2017 Plan) | 83.3k | $0.00 | $0 | | 01/02/2019 |
| 01/02/2019 | ACURA PHARMACEUTICALS, INC | ACUR | Exercise | Restricted Stock Units (2017 Plan) | 66.7k | $0.00 | $0 | | 01/02/2019 |
| 01/02/2018 | ACURA PHARMACEUTICALS, INC | ACUR | Exercise | Restricted Stock Units | 59.5k | $0.00 | $0 | | 01/02/2018 |
| 01/02/2018 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Restricted Stock Units | 66.7k | $0.00 | $0 | | 01/02/2018 |
| 12/14/2017 | ACURA PHARMACEUTICALS, INC | ACUR | Purchase | Common Stock | 335.7k | $0.10 | $33.6k | | 12/14/2017 |
| 05/31/2016 | DERMA SCIENCES, INC. | DSCI | Grant | Stock Option (right to buy) | 20k | $4.05 | $81k | | 05/31/2016 |
| 11/23/2011 | DERMA SCIENCES, INC. | DSCI | Purchase | common stock | 10k | $7.51 | $75.1k | | 11/23/2011 |
| 02/16/2011 | DERMA SCIENCES, INC. | DSCI | Sale | Common Stock | 16.2k | $10.31 | $167k | See FN | 02/15/2011 |
| 02/15/2011 | DERMA SCIENCES, INC. | DSCI | Sale | Common Stock | 56.8k | $10.10 | $573.3k | See FN | 02/15/2011 |
| 02/15/2011 | DERMA SCIENCES, INC. | DSCI | Sale | Common Stock | 600 | $11.36 | $6.8k | See FN | 02/15/2011 |
| 01/03/2011 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Director Stock Options | 15k | $0.00 | $0 | | 01/03/2011 |
| 01/04/2010 | ACURA PHARMACEUTICALS, INC | ACUR | Grant | Director Stock Options | 15k | $0.00 | $0 | | 01/04/2010 |
| 09/15/2009 | MEDASSETS INC | MDAS | Sale | Common Stock | 55.9k | $0.00 | $0 | See footnote | 09/15/2009 |
| 12/17/2008 | DERMA SCIENCES, INC. | DSCI | Purchase | Common Stock | 15k | $0.38 | $5.7k | | 12/12/2008 |
| 12/16/2008 | DERMA SCIENCES, INC. | DSCI | Purchase | Common Stock | 14.7k | $0.32 | $4.7k | | 12/12/2008 |
| 12/12/2008 | DERMA SCIENCES, INC. | DSCI | Purchase | Common Stock | 99k | $0.25 | $24.8k | | 12/12/2008 |